Efficacy and Safety of the Hcoil Deep TMS for the Treatment of Cannabis Addiction
Phase 1
- Conditions
- Marijuana Abuse
- Registration Number
- NCT00543036
- Lead Sponsor
- Shalvata Mental Health Center
- Brief Summary
Evaluation of efficacy and safety of H-coil deep transcranial magnetic stimulation 9 week treatment trial for cannabis addiction as assessed by measures of drug intake and craving.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Male and Female, aged 21-70 years, who meet DSM-IV TR diagnostic criteria for cannabis abuse and are motivated to quit cannabis use as assessed in the screening visit and gave their written informed consent to participate in the study.
Exclusion Criteria
- History of a primary major psychiatric other then cannabis abuse, or cognitive disorder according to DSM-IV TR criteria.
- Hamilton depression scale rated 25 and above (moderate to severe depression)
- Current alcohol or other substance abuse or dependence
- Alcohol or other substance abuse or dependence during the last 12 months before recruitment.
- History of or evidence of significant brain malformation,neoplasm, head injury, cerebral vascular events,neurodegenerative disorder or brain surgery.
- Severe somatic co-morbidity
- History of seizures Cardiac pace maker or other electronic implants Pregnancy and lactation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Shalvata Mental Health Center
🇮🇱Hod-HaSharon, Israel